The population attributable fraction of cases due to gatherings and groups with relevance to COVID-19 mitigation strategies.
COVID-19
gatherings
population attributable fraction (PAF)
Journal
Philosophical transactions of the Royal Society of London. Series B, Biological sciences
ISSN: 1471-2970
Titre abrégé: Philos Trans R Soc Lond B Biol Sci
Pays: England
ID NLM: 7503623
Informations de publication
Date de publication:
19 07 2021
19 07 2021
Historique:
entrez:
31
5
2021
pubmed:
1
6
2021
medline:
11
6
2021
Statut:
ppublish
Résumé
Many countries have banned groups and gatherings as part of their response to the pandemic caused by the coronavirus, SARS-CoV-2. Although there are outbreak reports involving mass gatherings, the contribution to overall transmission is unknown. We used data from a survey of social contact behaviour that specifically asked about contact with groups to estimate the population attributable fraction (PAF) due to groups as the relative change in the basic reproduction number when groups are prevented. Groups of 50+ individuals accounted for 0.5% of reported contact events, and we estimate that the PAF due to groups of 50+ people is 5.4% (95% confidence interval 1.4%, 11.5%). The PAF due to groups of 20+ people is 18.9% (12.7%, 25.7%) and the PAF due to groups of 10+ is 25.2% (19.4%, 31.4%). Under normal circumstances with pre-COVID-19 contact patterns, large groups of individuals have a relatively small epidemiological impact; small- and medium-sized groups between 10 and 50 people have a larger impact on an epidemic. This article is part of the theme issue 'Modelling that shaped the early COVID-19 pandemic response in the UK'.
Identifiants
pubmed: 34053263
doi: 10.1098/rstb.2020.0273
pmc: PMC8165584
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
20200273Subventions
Organisme : Medical Research Council
ID : MC_PC_19067
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_PC_19067/2
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/S004793/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/V038613/1
Pays : United Kingdom
Références
BMC Infect Dis. 2009 Jan 20;9:5
pubmed: 19154612
Proc Biol Sci. 2014 Apr 30;281(1785):20140268
pubmed: 24789897
PLoS Comput Biol. 2012;8(3):e1002425
pubmed: 22412366
PLoS One. 2016 Aug 18;11(8):e0160378
pubmed: 27536770
Lancet Infect Dis. 2020 Jan;20(1):23
pubmed: 31876493
J R Soc Interface. 2018 Jan;15(138):
pubmed: 29367241
J Epidemiol Glob Health. 2011 Dec;1(1):33-60
pubmed: 23856374
Int J Epidemiol. 2017 Jun 01;46(3):976-982
pubmed: 28472445
Int J Environ Res Public Health. 2013 Jul 16;10(7):2932-43
pubmed: 23863613
PLoS Med. 2008 Mar 25;5(3):e74
pubmed: 18366252
Emerg Infect Dis. 2010 May;16(5):809-15
pubmed: 20409371
BMC Public Health. 2010 Dec 21;10:778
pubmed: 21176155
Proc Biol Sci. 2013 Jun 26;280(1765):20131037
pubmed: 23804621
Lancet Infect Dis. 2012 Jan;12(1):66-74
pubmed: 22192131
J R Soc Interface. 2012 Nov 7;9(76):2826-33
pubmed: 22718990
Science. 2021 Feb 5;371(6529):
pubmed: 33303686
Vaccine. 2018 Jul 25;36(31):4603-4609
pubmed: 29954630